Related Experiment Video
Updated: Jun 30, 2025

Author Spotlight: Investigating the Pathophysiology of Eosinophilic Esophagitis
Published on: May 10, 2024
[Eosinophilic fasciitis: From pathophysiology to therapeutics]
S Knapp1, L Bolko2, A Servettaz3
1Service de médecine interne, maladie infectieuse et immunologie clinique, hôpital Robert-Debré, CHU de Reims, rue du Général-Kœnig, 51092 Reims cedex, France.
Eosinophilic fasciitis (EF) is a rare disorder causing painful swelling and stiffness. Recent advancements offer new diagnostic tools and targeted therapies like IL-6 inhibitors for improved patient outcomes.
Area of Science:
- Rheumatology
- Dermatology
- Immunology
Context:
- Eosinophilic fasciitis (EF) is a rare connective tissue disorder.
- Characterized by painful edema, induration, arthralgia, and limited range of motion.
- Impacts quality of life due to functional impairment.
Purpose:
- Review latest diagnostic, pathophysiological, and therapeutic developments in EF.
- Highlight the role of MRI and deep skin biopsy in diagnosis.
- Discuss EF in patients treated with immune checkpoint inhibitors.
Summary:
- Diagnosis relies on deep skin biopsy showing fascial edema, sclerofibrosis, and inflammation.
- Pathophysiology remains poorly understood; management lacks randomized trials.
- First-line treatment includes corticosteroids and methotrexate; targeted therapies like IL-6 inhibitors show promise.
Impact:
- Improved diagnostic accuracy through advanced imaging and biopsy techniques.
- Emerging targeted therapies offer new hope for managing EF.
- Enhanced understanding of EF pathophysiology may lead to novel treatment strategies.
Related Concept Videos
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma-II: Pathophysiology and Classification
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Types of Intermediate Filaments
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...

